People in the News

Premium

Frank Witney has been named chief commercial officer at Affymetrix. As CCO, Witney is charged with integrating the commercial teams of Affy and its recently acquired companies, Panomics, True Materials, and USB.

Witney joined Panomics, formerly Genospectra, as CEO in 2002. Prior to that, he served as president of drug discovery tools at PerkinElmer Life sciences.

Witney was a postdoc fellow at the National Institutes of Health and holds a PhD in molecular and cell biology from Indiana University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.

Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.

A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.

In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.